Q4 2024 Senzime AB (publ) Earnings Call Transcript

Feb 17, 2025 / 01:00 PM GMT

Key Points

Positve
  • Senzime AB (SNZZF) reported a significant growth of 65% in 2024, reaching 58.5 million Swedish krona in sales.
  • The US market was a major growth driver with a 72% increase, contributing significantly to the company's overall performance.
  • The launch of the next-generation Tetragraph system was well-received, positioning the company for future growth.
  • Senzime AB (SNZZF) secured additional funding through a direct share issue, targeting institutional investors.
  • The company has established strong industrial partnerships, including collaborations with Philips and GE Healthcare, enhancing its market reach.
Negative
  • The introduction of the next-generation Tetragraph system caused a short-term impact on Q4 sales as customers shifted their purchasing decisions.
  • Operating expenses remained flat despite significant investments, indicating potential challenges in cost management.
  • The European market faced challenges with longer sales processes and budget constraints for new technology adoption.
  • There was a dip in gross margin in the US due to larger volume deals and different sales strategies for hardware.
  • The company anticipates the need for additional funding to achieve cash flow profitability, indicating ongoing financial challenges.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SEZI.ST - Senzime AB (publ)
Q4 2024 Senzime AB (publ) Earnings Call
Feb 17, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to this queue for 2024 presentation with Senam. My name is Klaus Pain, equity analyst at Carnegie, and I will be moderating the Q&A session. But to presentanim's Q4 report with me in the studio, I have Philip Siber.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, very welcome.

Thank you.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
And I give the word to you, Philip.

Thank you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot